HomeInvestors HealthAstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy... AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition (AZN:NASDAQ) By BOMAR ENT. March 17, 2025 FacebookTwitterPinterestWhatsApp Roland Magnusson EsoBiotec SA has entered into a definitive agreement to be acquired by AstraZeneca (NASDAQ:AZN) for up to $1 billion, on a cash and debt-free basis, it said on Monday. The deal includes an initial payment of $425 million on closing, and up Source link Previous articleBeating the StreetNext articleKnit Socks!: 17 Classic Patterns for Cozy Feet latest articles explore more Reminiscences of a Stock Operator Performant Healthcare: Decent Quarter And Guidance But Valuation Remains A Concern – Hold Swing Trading Strategies For Beginners: Learn Stocks and Options to Build Passive Income From Home (3 Hour Crash Course) Warren Buffett’s Advice on What To Do When the Stock Market Crashes Trading Psychology: Start A Winning Attitude For Investing In Forex, Stock, Swing, Day, Options. Be A Successful Investor Creating Your Passive Income With Strategies... Tesla Energy Is Picking-Up The Slack LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
